Redirect Notice
 The previous page is sending you to https://www.researchgate.net/figure/Overview-of-the-tofacitinib-phase-3-OCTAVE-clinical-programme-bd-twice-daily-n_fig1_355128603.

 If you do not want to visit that page, you can return to the previous page.